Grant Glues Together Research Experts To Tackle Incurable Diseases (The Wertheim UF Scripps Institute)
UF researcher Thomas Kodadek’s team has won a prestigious international grant to collaborate with Merck KGaA on developing “molecular glue degraders,” a novel technology that harnesses the body’s recycling system to treat previously undruggable diseases like aggressive cancers and brain disorders.
HiPerGator Supercomputer Accelerates Diabetes Drug Discovery (UF Health)
Using a blend of computer modeling, structural and cell-based studies, UF researchers have designed a group of potential diabetes drugs that reprogram insulin-resistant cells into a healthier state while limiting side effect risks of older medications.
Tech Tuesday: University of Florida Lab Showcases How Molecular Motors Can Improve Human Life (WCJB TV20)
In this week’s Tech Tuesday, UF Innovate highlights Myosin Therapeutics, a biomedical company developing myosin inhibitors to treat cancer.
Tech Tuesday: UF Innovate and Scad Media Show Us How Leaders at a UF Campus in South Florida Are Focusing on Biomedical Research (WCJB TV20)
In this week’s Tech Tuesday, UF Innovate highlights The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology. Located in Jupiter, Florida, the institute is part of the University of Florida and focuses on biomedical research, education, and collaboration across scientific disciplines.
How Cells Power Down During Viral Attack
A team of UF researchers has uncovered how cells temporarily shut down protein production during viral attack, a discovery that could shape future antiviral drug development.